When medical device and drug companies hit crisis mode—and we’re talking nationwide class actions with thousands of plaintiffs—they call on Reed Smith.
Reed Smith’s product liability department beat back three major class or mass actions.
Partners Thomas Yoo and Melissa Geist in January 2014 resolved nearly 4,000 claims that Merck & Co.’s contraceptive product NuvaRing caused fatal blood clots, putting an end to more than four years of litigation. The company settled for $100 million—far less than other companies have doled out in similar suits over birth-control products. Bayer AG has paid $1.6 billion to resolve similar suits over oral contraceptives Yaz and Yasmin.
The Reed Smith lawyers got that favorable settlement, Yoo said, because they refused to take things lying down.
Download the PDF to read more!